Exposure and Biomonitoring Division, Environmental Health Science and Research Bureau, Environmental and Radiation Health Sciences Directorate, Healthy Environments and Consumer Safety Branch, Health Canada, AL: 2203 B, 251 Sir Frederick Banting Driveway, Ottawa, ON, K1A 0K9, Canada.
Anal Bioanal Chem. 2023 Jan;415(2):303-316. doi: 10.1007/s00216-022-04407-7. Epub 2022 Nov 8.
Humans are often exposed to phthalates and their alternatives, on account of their widespread use in PVC as plasticizers, which are associated with harmful human effects. While targeted biomonitoring provides quantitative information for exposure assessment, only a small portion of phthalate metabolites has been targeted. This results in a knowledge gap in human exposure to other unknown phthalate compounds and their metabolites. Although the non-targeted analysis (NTA) approach is capable of screening a broad spectrum of chemicals, there is a lack of harmonized workflow in NTA to generate reproducible data within and between different laboratories. The objective of this study was to compare two different NTA data acquisition modes, the data-dependent (DDA) and independent (DIA) acquisition (DDA), as well as two data analysis approaches, based on diagnostic ions and Compound Discoverer software for the prioritization of candidate precursors and identification of unknown compounds in human urine. Liquid chromatography coupled to high-resolution mass spectrometry was used for sample analysis. The combination of three-diagnostic-ion extraction and DDA data acquisition was able to improve data filtering and data analysis for prioritizing phthalate metabolites. With DIA, 25 molecular features were identified in human urine, while 32 molecular features were identified in the same urine samples using DDA data. The number of molecular features identified with level 1 confidence was 11 and 9 using DIA and DDA data, respectively. The study demonstrated that besides sample preparation, the impact of data acquisition must be taken into account when developing a NTA method and a consistent protocol for evaluating such an impact is necessary.
人类经常接触邻苯二甲酸酯及其替代品,因为它们广泛用于聚氯乙烯作为增塑剂,这与对人体有害的影响有关。虽然有针对性的生物监测为暴露评估提供了定量信息,但只有一小部分邻苯二甲酸代谢物被靶向。这导致了人类对其他未知邻苯二甲酸化合物及其代谢物的暴露存在知识空白。虽然非靶向分析(NTA)方法能够筛选广泛的化学物质,但在 NTA 中缺乏标准化的工作流程,无法在不同实验室内部和之间生成可重复的数据。本研究的目的是比较两种不同的 NTA 数据采集模式,即基于诊断离子和化合物发现者软件的依赖于数据的(DDA)和独立(DIA)采集(DDA),以及两种数据分析方法,用于优先考虑候选前体并鉴定人尿中的未知化合物。采用液相色谱-高分辨质谱联用技术进行样品分析。采用三诊断离子提取和 DDA 数据采集相结合的方法,能够改善数据过滤和数据分析,以优先考虑邻苯二甲酸代谢物。采用 DIA 技术,在人尿中鉴定出 25 个分子特征,而采用 DDA 数据在相同的尿样中鉴定出 32 个分子特征。采用 DIA 和 DDA 数据分别鉴定到 11 个和 9 个具有 1 级置信度的分子特征。研究表明,除了样品制备外,在开发 NTA 方法时必须考虑数据采集的影响,并且需要评估这种影响的一致协议。